Outcome of Combined Botulinum Toxin A Injection and Gastric Balloon Implantation in Obesity Treatment
NCT05872932 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 131
Last updated 2025-01-22
Summary
Obesity, which is defined as the accumulation of fat in the body to a degree that impairs health, is defined as a serious public health problem and it is estimated that 13% (approximately 650 million) of the entire world population is obese.
There are different methods in the fight against obesity, one of these methods is bariatric interventions. Although bariatric surgery is the most effective of these procedures, the tendency to endoscopic methods is increasing due to the surgical risk. Gastric balloon is the most common endoscopic method. In addition, gastric botox is among the methods used.
Health consequences of endoscopic interventions have been widely investigating and while gastric balloon recommended as safe and effective method, the situation for gastric botox is controversial.
Although it seems as gastric balloon is an office procedure and safely performed, especially the first week is difficult process for patients. It can also end with abdominal pain, nausea, retching, and eventually a process leading to premature removal of the balloon. In Italian study, Genco et al. reported that out of 2515 patients 11 patients (0.44%) balloon removed due to psychological intolerance. While the reported rate of early gastric balloon removal generally ranges from 0.44% to 16%, De Castro ML. et al. reported the early removal rate as 20%. While the complications related to the gastric balloon are as stated, problems such as nausea, vomiting and cramps after the gastric botox procedure are either not reported or not seen at all.
Therefore, we hypothesize that sequential endoscopic procedures (first botox application followed by gastric balloon placement) will reduce these early complications (abdominal pain, nausea, retching) and early removal of the gastric balloon.
The only study we have reached regarding combined therapy was done in Turkey. Kanlıöz M et al. reported that combining botox and balloon was found to be more effective in losing weight, but it was stated that it had more side effects. In this study, we think that the side effects may already be related to the balloon. As James A et al. stated in their experimental work, the effectiveness of botox is time dependent. It has been stated that the efficacy is optimal after 6 hours in injections to the pyloric region.The fact that the balloon was inserted in the same session, without waiting for enough time after the botox procedure to be effective, may have reduced the possible protective effect of the botox.
Conditions
Interventions
- PROCEDURE
-
gastric balloon implantation
After diagnostic endoscopy if there is no any gastric pathology that would be contraindication for balloon placement a gastric balloon will be placed
- PROCEDURE
-
botulinum toxin A injection
After diagnostic endoscopy if there is no any gastric pathology that would be contraindication Botox injection and balloon placement, 200 U of Botox A will be injected to antrum and fundus. And 1 week later gastric balloon will be implanted
Sponsors & Collaborators
-
Sebahattin Celik MD
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-12-30
- Primary Completion
- 2024-06-30
- Completion
- 2024-12-30
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Spatz Adjustable Balloon for Obesity (SABO)
NCT02812160 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of Orbera365™ Intragastric Balloon System
NCT07062094 ·Status: RECRUITING
-
The Safety and Efficacy of the ReShape Intragastric Balloon in Obese Subjects
NCT01061385 ·Status: COMPLETED ·Phase: NA
-
Spatz3 Adjustable Balloon System® (Spatz3) Post Approval Study
NCT05086302 ·Status: COMPLETED
-
Endoscopic Treatment of Overweight and Mild Obesity with ORBERA365
NCT06785233 ·Status: RECRUITING ·Phase: NA
-
Obalon US Commercial Registry
NCT03688256 ·Status: COMPLETED
-
Nonsurgical Reversible Obesity Treatment (NROT1)
NCT05420506 ·Status: UNKNOWN ·Phase: NA
-
Intragastric Balloon, Air Versus Fluid Filled: Randomized Prospective Study
NCT02129296 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Prospective Multicenter Post Approval Study of the ReShape™ Integrated Dual Balloon System in Obese Subjects
NCT02927665 ·Status: UNKNOWN
-
Effectiveness Gastric Balloon in Obese Adolescents
NCT04209842 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study of BioEnterics® Intragastric Balloon (BIB®) System to Assist in the Weight Management of Obese Subjects
NCT00730327 ·Status: COMPLETED ·Phase: NA
-
Study on the Safety and Efficacy of Domestic Single-Port Robot-Assisted Metabolic Bariatric Surgery.
NCT07335731 ·Status: RECRUITING ·Phase: NA
-
A Study to Compare the 12-month Spatz3 Adjustable Balloon With a 6-month Non Adjustable Balloon
NCT04800835 ·Status: COMPLETED ·Phase: NA
-
Intragastric Balloon for Treatment of Overweight and Obesity: Which is the Best Filling Volume?
NCT06673550 ·Status: RECRUITING ·Phase: NA
-
Comparative Study of Intragastric Balloon and Pharmacotherapy for Non-Morbid Obesity
NCT00355979 ·Status: UNKNOWN ·Phase: PHASE3
-
Effects of Intragastric Balloon Surgery and Sleeve Gastrectomy on Brain Function
NCT05127213 ·Status: UNKNOWN ·Phase: NA
-
Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365')
NCT07195708 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
CoolSculpting Treatment in the Upper Arms
NCT02939105 ·Status: COMPLETED ·Phase: NA
-
The USGI Medical ESSENTIAL Study for Weight Loss
NCT01958385 ·Status: COMPLETED ·Phase: NA
-
Effect of Gastric Balloon in Morbid Obesity: Prospective Study
NCT02128165 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Evaluation of Bariatric Endoscopic Antral Myotomy (BEAM) as a Treatment for Obesity
NCT05713071 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effects of Intragastric Balloon on Bone, Metabolic and Respiratory Parameters
NCT01598233 ·Status: COMPLETED ·Phase: PHASE3
-
Bariatric Arterial Embolization for Morbid Obesity
NCT02786108 ·Status: UNKNOWN ·Phase: PHASE3
-
Obalon in Children With Severe Obesity
NCT02137330 ·Status: COMPLETED ·Phase: PHASE3
-
The BALLOON- (BALLOon Treatment for Obesity in Norway) Pilot Study
NCT03576833 ·Status: UNKNOWN ·Phase: NA